Stock Comparison
BSX vs SYK
Boston Scientific Corp and Stryker Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$73.25B
$128.32B
P/E (TTM)
20.5
34.6
Forward P/E
15.4
22.3
Price/Sales
3.5
5.0
Price/Book
2.9
5.4
EV/EBITDA
15.1
20.1
Dividend Yield
—
0.76%
Profitability
Net Margin
17.48%
13.21%
Operating Margin
21.60%
21.34%
Return on Equity
15.30%
16.50%
Return on Assets
6.19%
8.16%
Growth (YoY)
Revenue Growth
7.50%
9.40%
Earnings Growth
15.10%
44.10%
Price & Risk
Beta
0.6
0.8
52-Week High
$108.14
$391.42
52-Week Low
$42.63
$282.58
Analyst Target
$62.69
$382.04
Compare BSX and SYK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.